In contrast, AMPK is concurrently involved in inducing the expression of the glutamine transporter protein alanine-serine-cysteine transporter 2 (ASCT2), increasing glutamine consumption, which can induce glutamine deficiency in cancer cells [35]. The gene discussed is SLC1A5; the disease is cancer.